SCHEMBL5507018

SCHEMBL5507018

O=C(CCl)c1ccc2c(c1)NCCS2

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.44
MAPT P10636 3/20 0.44
MEN1 O00255 1/20 0.42
GAA P10253 1/20 0.42
KMT2A Q03164 1/20 0.42
HDAC1 Q13547 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
GSK3B P49841 3/20 0.40
HIF1A Q16665 2/20 0.40
TRPA1 O75762 1/20 0.40
MAPK1 P28482 1/20 0.40
HTT P42858 1/20 0.38
KDM4E B2RXH2 2/20 0.38
CTNNB1 P35222 2/20 0.36
WNT3A P56704 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
HPGD P15428 1/20 0.36
LMNA P02545 2/20 0.35
NEK2 P51955 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1238568 0.81 HTT (0.56) ALDH1A1MAPTMEN1GAAKMT2A
SCHEMBL2363066 0.81 ALDH1A1 (0.47) ALDH1A1MAPTMEN1GAAKMT2A
SCHEMBL29978912 0.77 ALDH1A1 (0.60) ALDH1A1MAPTMEN1GAAKMT2A
SCHEMBL753087 0.77 ALDH1A1 (0.60) ALDH1A1MAPTMEN1GAAKMT2A
SCHEMBL2204998 0.75 HTT (0.69) ALDH1A1MAPTMEN1KMT2AHDAC1
SCHEMBL1996452 0.74 L3MBTL1 (0.49) ALDH1A1MEN1GAAKMT2ASMN1; SMN2
SCHEMBL1997763 0.73 HDAC1 (0.46) ALDH1A1MAPTMEN1GAAKMT2A
SCHEMBL1997553 0.73 HDAC1 (0.46) ALDH1A1MAPTMEN1GAAKMT2A
SCHEMBL2004664 0.73 HPGD (0.57) ALDH1A1MAPTMEN1GAAKMT2A
SCHEMBL1997751 0.73 KMT2A (0.54) ALDH1A1MAPTMEN1GAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1799676-A2 NEW BICYCLIC ANTIBIOTICS Actelion Pharmaceuticals Ltd. (CH) 2007-06-27 EP disclosed
WO-2006032466-A2 NEW BICYCLIC ANTIBIOTICS ACTELION PHARMACEUTICALS LTD (CH) 2006-03-30 WO disclosed